Pinar has a wealth of experience in leading projects from a strategic and technical perspective, helping clients to demonstrate the value of innovations in medical care, and supporting both pharmaceuticals and medical devices.
She specializes in health economic modeling and evidence synthesis with experience across a range of chronic (oncology, inflammatory disease, metabolic disease including diabetes, neurology, ophthalmology) and infectious (meningitis, human immunodeficiency virus, Group A streptococcus, influenza/respiratory syncytial virus) indications, as well as specific experience with gene therapies for rare and ultra-rare diseases.
Pinar holds a Bachelor’s degree from Princeton University and Master’s degree from Harvard, and has authored numerous peer-reviewed publications.